Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme
Open Access
- 29 June 2021
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 289 (20), 6099-6118
- https://doi.org/10.1111/febs.16086
Abstract
Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the initial rate-limiting step in the degradation of the essential amino acid tryptophan along the kynurenine pathway. When discovered more than 50 years ago, IDO1 was thought to be an effector molecule capable of mediating a survival strategy based on the deprivation of bacteria and tumor cells of the essential amino acid tryptophan. Since 1998, when tryptophan catabolism was discovered to be crucially involved in the maintenance of maternal T-cell tolerance, IDO1 has become the focus of several laboratories around the world. Indeed, IDO1 is now considered as an authentic immune regulator not only in pregnancy, but also in autoimmune diseases, chronic inflammation, and tumor immunity. However, in the last years, a bulk of new information-including structural, biological, and functional evidence-on IDO1 has come to light. For instance, we now know that IDO1 has a peculiar conformational plasticity and, in addition to a complex and highly regulated catalytic activity, is capable of performing a nonenzymic function that reprograms the expression profile of immune cells toward a highly immunoregulatory phenotype. With this state-of-the-art review, we aimed at gathering the most recent information obtained for this eclectic protein as well as at highlighting the major unresolved questions.Funding Information
- H2020 European Research Council (899838−ENHANCIDO)
- Associazione Italiana per la Ricerca sul Cancro (AIRC 2019‐23084)
This publication has 178 references indexed in Scilit:
- Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease BrainPLOS ONE, 2013
- Characterization and Comparative Profiling of MicroRNAs in a Sexual Dimorphism Insect, Eupolyphaga sinensis WalkerPLOS ONE, 2013
- The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-DioxygenaseJournal of the American Chemical Society, 2012
- Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanismProceedings of the National Academy of Sciences of the United States of America, 2010
- Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenaseProteins, 2010
- Endosomes: A legitimate platform for the signaling trainProceedings of the National Academy of Sciences of the United States of America, 2009
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active TargetJournal of the American College of Surgeons, 2009
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences of the United States of America, 2008
- Evolution of Vertebrate Indoleamine 2,3-DioxygenasesJournal of Molecular Evolution, 2007
- Heme-Containing OxygenasesChemical Reviews, 1996